Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing
← catalyst calendarSponsored by Pharmanutra S.p.a. (industry) · PHN.MI — their whole pipeline →. With Artialis.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Randomized · Triple · Treatment
Enrollment
100estimated
Sites
6
Country
Belgium
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-10-01 | actual | When the study began enrolling |
| Primary completion | May 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2025-12-23 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-23 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Fracture Femur
- Fracture Tibia
Interventions
- Dietary supplement: CFA-based food supplement
- Other: Placebo
Primary outcome
what the primary-completion date above is the date OFRadiographic Assessment of Callus Formation using the modified Radiographic Union Score for Tibia (mRUST).
measured 6 weeks after fracture stabilization
Permalink · PHN.MI's whole pipeline · Catalyst calendar · Every registered study · What changed